“…BACKGROUND A consequence of the broad and nonquantitative specifications for the major and minor steroids is that compendia1 standards may not ensure pharmaceutical equivalence. This impurity, if not removed prior to analysis, would interfere with both GLC methods (3,4). For example, 17P-estradio1, although a minor component, exhibits 12 times the potency of the major steroid, estrone (6).…”